Anti-Neutrophil Cytoplasm Autoantibodies (ANCA). The Need for Specific and Sensitive Assays

References

• Kallenberg C. G.M, Brouwer E., Weening J. J., Tervaert J. W. C. Anti-neutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential. Kidney Int 1994; 46: 1–15
   PubMed Web of Science ®Google Scholar
• Goldschmeding R., van der Schoot C. E., ten Bokkel Huinink D., et al. Wegener's granulomatosis autoantibodies identify a novel diisopropylfiuorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest 1989; 84: 1577–1587
   PubMed Web of Science ®Google Scholar
• Jenne D., Tschopp J., Ludemann J., Utecht B., Gross W. Wegener's autoantigen decoded. Nature 1990; 346: 520
   PubMed Web of Science ®Google Scholar
• Niles J. L., McCluskey R. T., Ahmad M. F., Arnaout M. A. Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood 1989; 74: 1888–1893
   PubMed Web of Science ®Google Scholar
• Wiik A., Rasmussen N., Wieslander J. Methods to detect autoantibodies to neutrophilic granulocytes. Manual of biological markers of disease, W. J. Van Venrooij, R. N. Maini. Kluwer Academic Publishers, Dordrecht 1993; A9: 1–A914
   Google Scholar
• Hagen E. C, Andrassy K., Chernok E., et al. The value of indirect immunofluorescence and solid phase techniques for ANCA detection. A report on the first phase of an international cooperative study on the standardization of ANCA assays. EEC/BCR Group for ANCA Assay Standardization. J Immunol Methods 1993; 159: 1–16
   PubMed Web of Science ®Google Scholar
• Goldschmeding R. Target antigens of antineutrophil cytoplasmic antibodies. Amsterdam 1992, Thesis
   Google Scholar
• Braun M. G., Csernok E., Gross W. L., Muller Herme-link H. K. Proteinase 3, the target antigen of anticy-toplasmic antibodies circulating in Wegener's granulomatosis. Immunolocalization in normal and pathologic tissues. Am J Pathol 1991; 139: 831–838
   PubMed Web of Science ®Google Scholar
• Egesten A., Bretongorius J., Guichard J., Gullberg U., Olsson I. The heterogenity of azurophil granules in neutrophil promyelocytes: Immunogold localization of myeloperoxidase, cathepsin, G. elastase, proteinase 3, and bactericidal permeability increasing protein. Blood 1994; 83: 2984–2994
   Web of Science ®Google Scholar
• Rao N. V., Wehner N. G., Marshall B. C, Gray W. R., Gray B. H., Hoidal J. R. Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties. J Biol Chem 1991; 266: 9540–9548
   PubMed Web of Science ®Google Scholar
• Dalpe G., Beliveau A., Menard H. A. Cross-Reactivity of an Anti-Proteinase 3 Antibody to Elastase. Autoimmunity 1993; 16: 311–313
   PubMed Web of Science ®Google Scholar
• Nassberger L., Hansson A. L., Mårtensson U. Lack of cross-reactivity of c-ANCA to elastase and cathepsin G. Autoimmunity 1993; 14: 259
   PubMed Web of Science ®Google Scholar
• Bini P., Gabay J. E., Teitel A., Melchior M., Zhou J. L., Elkon K. B. Antineutrophil cytoplasmic autoantibodies in Wegener's granulomatosis recognize conformational epitope(s) on proteinase 3. J Immunol 1992; 149: 1409–1415
   PubMed Web of Science ®Google Scholar
• Plow E. F. Leukocyte elastase release during blood coagulation. J Clin Invest 1982; 69: 564–572
   PubMed Web of Science ®Google Scholar
• Baslund B., Segelmark M., Wiik A., Szpirt W., Petersen J., Wieslander J. Screening for antineutrophil cytoplasmic antibodies (ANCA): is indirect immunofluorescence the method of choice?. Clin Exp Immunol 1995; 99: 486–492
   PubMed Web of Science ®Google Scholar
• Bergenfeldt M., Axelsson L., Ohlsson K. Release of neutrophil proteinase 4(3) and leukocyte elastase during phagocytosis and their interaction with proteinase inhibitors. Scand J Clin Lab Invest 1992; 52: 823–829
   PubMed Web of Science ®Google Scholar
• Weiss S. J. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365–376
   PubMed Web of Science ®Google Scholar
• Venge P., Bergstrand H., Håkansson L. Neutrophils and eosinophils. Textbook of Rheumatology, W. N. Kelley, E. D. Harris, S. Ruddy, C. B. Sledge, 1993; 269–285
   Google Scholar
• Falk R. J., Jennette J. C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and cresentic glomerulonephritis. N Engl J Med 1988; 318: 1651–1657
   PubMed Web of Science ®Google Scholar
• Wieslander J. How are antineutrophil cytoplasmic autoantibodies detected?. Am J Kidney Dis 1991; 18: 154–158
   PubMed Web of Science ®Google Scholar
• Gross W. L., Schmitt W. H., Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 1993; 91: 1–12
   PubMed Web of Science ®Google Scholar
• Zhao M. H., Jones S. J., Lockwood C. M. Bactericidal/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin Exp Immunol 1995; 99: 49–56
   PubMed Web of Science ®Google Scholar
• Pesce A. J., Michael J. G. Artefacts and limitations of enzyme immunoassay. J Immunol Methods 1992; 150: 111–119
   PubMed Web of Science ®Google Scholar
• Segelmark M., Baslund B., Wieslander J. Some patients with anti-myeloperoxidase autoantibodies have a c-ANCA pattern. Clin Exp Immunol 1994; 96: 458–465
   PubMed Web of Science ®Google Scholar
• van der Woude F. J., Rasmussen N., Lobatto S., et al. Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; 1: 425–429
   PubMed Web of Science ®Google Scholar
• Nolle B., Specks U., Ludemann J., Rohrbach M. S., DeRemee R. A., Gross W. L. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis. Ann Intern Med 1989; 111: 28–40
   PubMed Web of Science ®Google Scholar
• Cohen Tervaert J.W., van der Woude F. J., Fauci A. S., et al. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 1989; 149: 2461–2465
   PubMedGoogle Scholar
• Ludemann J., Csernok E., Ulmer M., et al. Antineutrophil cytoplasm antibodies in Wegener's granulomatosis: immunodiagnostic value, monoclonal antibodies and characterization of the target antigen. Neth J Med 1990; 36: 157–162
   PubMed Web of Science ®Google Scholar
• Davenport A., Lock R. J., Wallington T. B., Feest T. G. Clinical significance of anti-neutrophil cytoplasm antibodies detected by a standardized indirect immunofluorescence assay. Q J Med 1994; 87: 291–299
   PubMedGoogle Scholar
• Rao J. K., Allen N. B., Feussner J. R., Weinberger M. A prospective study of neutrophil cytoplasmic antibody (c-ANCA) and clinical criteria in diagnosing Wegener's granulomatosis. Lancet 1995; 346: 926–931
   PubMed Web of Science ®Google Scholar
• Savage C. O. S., Winnearls C. G., Jones S., Marshall P. D., Lockwood C. M. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet, i: 1389–1393
   Google Scholar
• Savige J. A., Yeung S. P., Gallicchio M., Davies D. J. Two ELISAs to detect anti-neutrophil cytoplasm antibodies (ANCA) in various vasculitides. Pathology 1989; 21: 282–287
   PubMed Web of Science ®Google Scholar
• Rasmussen N., Sjolin C, Isaksson B., Bygren P., Wieslander J. An ELISA for the detection of antineutrophil cytoplasm antibodies (ANCA). J Immunol Methods 1990; 127: 139–145
   PubMed Web of Science ®Google Scholar
• Goldschmeding R., van der Schoot C. E., van der Snoek M. A., Von dem Borne A. E. G. K. A monoclonal antibody against the 29 kD ANCA-antigen: Application as catching antibody in a sandwich-ELlSA for ANCA detection. APMIS 1989; 97(6)47
   Google Scholar
• Sommarin Y., Rasmussen N., Wieslander J. Characterization of monoclonal antibodies to proteinase 3 and application in the study of epitopes for cANCA. Exp Nephrol 1995; 3: 249–256
   PubMedGoogle Scholar
• Savige J. A., Smith C, Change L., Duggan J. C. Anti-neutrophil cytoplasm antibodies (ANCA) in a patient with the vasculitis of myelodysplasia[letter]. Br J Haematol 1991; 78: 583–584
   PubMed Web of Science ®Google Scholar
• Niles J. L. Value of tests for antineutrophil cytoplasmic autoantibodies in the diagnosis and treatment of vasculitis. Curr Opin Rheumatol 1993; 5: 18–24
   PubMedGoogle Scholar
• Cohen Tervaert J.W., Huitema M. G., Hene R. J., et al. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 1990; 336: 709–711
   PubMed Web of Science ®Google Scholar
• Kerr G. S., Fleisher T. A., Hallahan C. W., Leavitt R. Y., Fauci A. S., Hoffman G. S. Limited Prognostic Value of Changes in Antineutrophil Cytoplasmic Antibody Titer in Patients with Wegener's Granulomatosis. Arthritis Rheum 1993; 36: 365–371
   PubMed Web of Science ®Google Scholar
• Hoffman G. S., Kerr G. S., Leavitt R. Y., et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488–498
   PubMed Web of Science ®Google Scholar
• Cohen Tervaert J.W., Mulder L., Stegeman C, et al. Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders. Ann Rheum Dis 1993; 52: 115–120
   PubMed Web of Science ®Google Scholar
• Fienberg R., Mark E. J., Goodman M., McCluskey R. T., Niles J. L. Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis. Hum Pathol 1993; 24: 160–168
   PubMed Web of Science ®Google Scholar
• Gaskin G., Savage C. O., Ryan J. J., et al. Antineutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis. Nephrol Dial Transplant 1991; 6: 689–694
   PubMed Web of Science ®Google Scholar
• Cohen Tervaert J.W., Goldschmeding R., Elema J., et al. Association of autoantibodies to myeloperoxidase with different forms of vasculitis. Arthritis Rheum 1990; 33: 1264–1268
   PubMedGoogle Scholar
• Guillevin L., Visser H., Noel L. H., et al. Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome-62 patients. J Rheumatol 1993; 20: 1345–1349
   PubMed Web of Science ®Google Scholar
• Cohen Tervaert J.W., Limburg P. C, Elema J. D., et al. Detection of autoantibodies against myeloid lysosomal enzymes: A useful adjunct to classification of patients with biopsy-proven necrotizing arteritis. Am J Med 1991; 91: 59–66
   PubMed Web of Science ®Google Scholar
• Guillevin L., Lhote F. Distinguishing polyarteritis nodosa from microscopic polyangiitis and implications for treatment. Curr Opin Rheumatol 1995; 7: 20–24
   PubMedGoogle Scholar
• Savage C. O., Tizard J., Jayne D., Lockwood C. M., Dillon M. J. Antineutrophil cytoplasm antibodies in Kawasaki disease. Arch Dis Child 1989; 64: 360–363
   PubMed Web of Science ®Google Scholar
• Shaw G., Ronda N., Bevan J. S., Esnault V., Griffiths D. F., Rees A. Antineutrophil cytoplasmic antibodies (ANCA) of IgA class correlate with disease activity in adult Henoch-Schonlein purpura. Nephrol Dial Transplant 1992; 7: 1238–1241
   PubMed Web of Science ®Google Scholar
• O'Donoghue D. J., Nusbaum P., Noel L. H., Halbwachs Mecarelli L., Lesavre P. Antineutrophil cytoplasmic antibodies in IgA nephropathy and Henoch-Schonlein purpura. Nephrol Dial Transplant 1992; 7: 534–538
   PubMed Web of Science ®Google Scholar
• Ronda N., Esnault V. L. M., Layward L., et al. Antineutrophil cytoplasm antibodies (ANCA) of IgA isotype in adult Henoch-Schonlein purpura. Clin Exp Immunol 1994; 95: 49–55
   PubMed Web of Science ®Google Scholar
• Sinico R. A., Tadros M, Radice M, et al. LAck of IgA antineutrophil cytoplasmic antibodies in Henoch-Schonlein purpura and IgA nephropathy. Clin Immunol Immunopathol 1994; 73: 19–26
   PubMedGoogle Scholar
• McHugh N. J., James I. E., Plant G. T. Anticardiolipin and antineutrophil antibodies in giant cell arteritis. J Rheumatol 1990; 17: 916–922
   PubMed Web of Science ®Google Scholar
• Baranger T. A. R., Audrain M. A. P., Castagne A., Barrier J. H., Esnault V. L. M. Absence of antineutrophil cytoplasmic antibodies in giant cell arteritis. J Rheumatol 1994; 21: 871–873
   PubMed Web of Science ®Google Scholar
• Coremans I. E., Hagen E. C, Daha M. R., et al. Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum 1992; 35: 1466–1475
   PubMedGoogle Scholar
• Mulder A. H. L., Horst G., van Leeuwen M., Limburg P. C., Kallenberg C. G. M. Anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis: characterization and clinical correlates. Arthritis Rheum 1993; 36: 1054–1060
   PubMedGoogle Scholar
• Mulder A. H. L. Anti-neutrophil cytoplasmic antibodies in idiopathic inflammatory disorders. Thesis, 1994, Gronin-gen
   Google Scholar
• Cambridge G., Williams M., Leaker B., Corbett M., Smith C. R. Anti-Myeloperoxidase Antibodies in Patients with Rheumatoid Arthritis - Prevalence, Clinical Correlates, and IgG Subclass. Ann Rheum Dis 1994; 53: 24–29
   PubMed Web of Science ®Google Scholar
• Dolman K. M., Gans R. O. B., Vervaat T. J., et al. Vasculitis and Antineutrophil Cytoplasmic Autoantibodies Associated with Propylthiouracil Therapy. Lancet 1993; 342: 651–652
   PubMed Web of Science ®Google Scholar
• Saxon Shanahan A., Landers F., Ganz C. T., Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990; 86: 202–210
   PubMed Web of Science ®Google Scholar
• Mulder A. H. L., Broekroelofs J., Horst G., Limburg P. C, Nelis G. F., Kallenberg C. G. M. Anti-Neutrophil Cytoplasmic Antibodies (Anca) in Inflammatory Bowel Disease - Characterization and Clinical Correlates. Clin Exp Immunol 1994; 95: 490–497
   PubMed Web of Science ®Google Scholar
• Rump J. A., Scholmerich J., Gross V., et al. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiology 1990; 181: 406–413
   PubMed Web of Science ®Google Scholar
• Peen E., Aimer S., Bodemar G., et al. Antilactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease. Gut 1993; 34: 56–62
   PubMed Web of Science ®Google Scholar
• Ellerbroek M., Pool M. O., Ridwan B. U., et al. Neutrophil Cytoplasmic Antibodies (P-Anca) in Ulcerative Colitis. J Clin Pathol 1994; 47: 257–262
   PubMed Web of Science ®Google Scholar
• Broekroelofs J., Mulder A. H. L., Nelis G. F., Westerveld B. D., Tervaert J. W. C., Kallenberg C. G. M. Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in Sera from Patients with Inflammatory Bowel Disease (IBD) - Relation to Disease Pattern and Disease Activity. Dig Dis Sci 1994; 39: 545–549
   PubMed Web of Science ®Google Scholar
• Coremans I. E. M., Hagen E. C, Vandervoort E. A. M., Vanderwoude F. J., Daha M. R., Breedveld F. C. Autoantibodies to Neutrophil Cytoplasmic Enzymes in Felty's Syndrome. Clin Exp Rheumatol 1993; 11: 255–262
   PubMed Web of Science ®Google Scholar
• Pauzner R., Urowitz M., Gladman D., Gough J. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. J Rheumatol 1994; 21: 1670–1673
   PubMed Web of Science ®Google Scholar
• Schnabel A., Csernok E., Isenberg D. A., Mrowka C., Gross W. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Arthritis Rheum 1995; 38: 633–637
   PubMedGoogle Scholar